Lomond Therapeutics Completes Second and Third Closings
28 Mar 2025 //
PR NEWSWIRE
Expert Celebrates Lonitoclax Milestone in Clinical Development
17 Dec 2024 //
PR NEWSWIRE
Lomond Therapeutics Report Results for Lonitoclax, BCL-2 Inhibitor
09 Dec 2024 //
PR NEWSWIRE